Showing posts with label ACE inhibitor. Show all posts
Showing posts with label ACE inhibitor. Show all posts

Saturday, March 14, 2020

ACE inhibitors and statins may reduce mortality


ACE inhibitors and statins may reduce mortality
When any pneumonia can be fatal after age 65?
Dr KK Aggarwal
President CMAAO, HCFI and Past national President IMA

1.     Even with regular community acquired pneumonia the mortality rate higher in patients requiring hospitalization, being as high as 37 percent in patients admitted to the intensive care unit (ICU).
2.     A number of risk factors for mortality have been identified. Having two or three of the following variables have been associated with high risk in several studies: blood urea nitrogen greater than 20 mg/dL, diastolic blood pressure less than 60 mmHg, and/or respiratory rate above 30 per minute. These three variables plus confusion and age greater than 65 years constitute the CURB-65 score; patients with 0 or 1 of these factors are at low risk and can usually be treated as outpatients. Underlying comorbidity and the cause of pneumonia also affect the mortality risk.
3.     CAP has been associated with both short- and long-term risk of cardiac complications. CAP has been associated with acute cardiac events that may result from cardiac stress, hypoxemia, and inflammation.
4.     Most otherwise healthy children with pneumonia recover without sequelae, even if the pneumonia is complicated.
5.     Some people are prone to a severe immune overreaction -— a “cytokine storm” -— that can both sicken and kill patients who are infected with certain strains of flu virus. A cytokine storm is an overproduction of immune cells and their activating compounds (cytokines), which, in a flu infection, is often associated with a surge of activated immune cells into the lungs. The resulting lung inflammation and fluid build up can lead to respiratory distress and can be contaminated by a secondary bacterial pneumonia -- often enhancing the mortality in patients.

This little-understood phenomenon is thought to occur in at least several types of infections and autoimmune conditions, but it appears to be particularly relevant in outbreaks of new flu variants. Cytokine storm is now seen as a likely major cause of mortality in the 1918-20 "Spanish flu" -- which killed more than 50 million people worldwide -- and the H1N1 "swine flu" and H5N1 "bird flu" of recent years.

Drugs for the treatment of cytokine storm can be classified into the following types: OX40 IG, ACE inhibitors and Angiotensin II Receptor Blockers, Corticosteroids, Gemfibrozil, Free radical scavengers, TNF-alpha blockers.

NEJM study: Using Veterans Affairs (VA) databases, the researchers identified 8652 patients (98.6% male) who met the inclusion criteria (age ≥65; hospitalization for community-acquired pneumonia [CAP] or influenza during fiscal year 2000; ≥1 outpatient clinic visit during fiscal year 1999; and ≥1 active and filled prescription ≤90 days before admission). Among these patients, 8.9% were receiving statins and ACE inhibitors, 25.0% were receiving only ACE inhibitors, and 9.2% were receiving only statins. Nearly 10% of the patients died ≤30 days after admission. After adjustment for confounding variables, use of statins alone (odds ratio, 0.58; 95% confidence interval, 0.42–0.80), use of ACE inhibitors alone (OR, 0.84; 95% CI, 0.70–1.00), and use of statins plus ACE inhibitors (OR, 0.45; 95% CI, 0.31–0.66) all were significantly associated with decreased 30-day mortality. Use of nonstatin lipid-lowering agents was not associated with a survival benefit.

Who are high risk patients?

1.     Check SPO2 levels: If with fever. Cough and breathlessness the blood oxygen level SPO2 is low, it’s a sign of anoxia
2.     Check SPO2 levels: If with fever. Cough and breathlessness the blood oxygen level SPO2 drops by 4% on walking it’s a sign of anoxia
3.     Uncontrolled diabetes, blood pressure, asthma and heart failure


Why 65+ pneumococcal vaccination is a must?

People may recover from viral pneumonia but die of secondary pneumococcal pneumonia




Tuesday, December 17, 2019

Standard Treatment of Diabetic Nephropathy ( EGFR > 30): ACE Inhibitor OR AR Blocker PLUS SGLT-2 Inhibitor


Standard Treatment of Diabetic Nephropathy ( EGFR > 30): ACE Inhibitor OR AR Blocker PLUS SGLT-2 Inhibitor

Dr KK Aggarwal
President CMAAO and HCFI


Diabetic nephropathy or overt proteinuria (macroalbuminuria, or "severely increased albuminuria") is usually present with worse glycemic control, hypertension, glomerular hyperfiltration, or a genetic predisposition.

The earliest clinical manifestation of renal involvement in diabetes is an increase in albumin excretion (microalbuminuria, or "moderately increased albuminuria")

Glycemic control can partially reverse the glomerular hypertrophy and hyperfiltration, delay the development of elevated albumin excretion, stabilize or decrease protein excretion in patients with increased albumin excretion, and \can slow the progression of glomerular filtration rate decline.

ACE inhibitors OR ARBs can reduce the rate of kidney disease progression.

Do not combiner the two.

Also do not combine aliskiren, a direct renin inhibitor with ACE or ARBs.

Diabetic nephropathy with EGFR >30 mL/min per 1.73 m2 add SGLT-2 inhibitor canagliflozin or empagliflozin. They can reduce kidney disease progression, end-stage renal disease, and cardiovascular events and can potentially improve survival. However, they increase the rate of urinary tract infections and genital fungal infections and may increase the likelihood of lower limb amputation and fracture. SGLT-2 inhibitors are weak glucose-lowering agents and also costly.

Friday, September 16, 2011

#AskDrKK: Can patient with high blood pressure take Viagra group of drugs?

#DrKKAnswers:
Viagra group of drugs are typically well tolerated with only minor reductions in blood pressure in patients taking conventional antihypertensive drugs (ACE inhibitors, AR blockers, calcium blockers, beta blockers, and diuretics), even when used in combination.
Source:
1. Sildenafil Study Group. Am J Hypertens 2001; 14:70.
2. Am J Hypertens 2004; 17:1135.

Thursday, August 18, 2011

Emedinews: Dr Good Dr Bad : A patient on ACE inhibitors wanted to know whether he could take aspirin.

Situation: A patient on ACE inhibitors wanted to know whether he could take aspirin.
Dr. Bad: No, you cannot take aspirin.
Dr. Good: It can be given if it is a must.
Lesson: Though some evidences suggest that aspirin inhibits the acute affect of ACE inhibitors, most of the evidence do not support an inhibitive affect of aspirin on the long term outcome of ACE inhibitors.

Tuesday, August 16, 2011

Emedinews: Makesure: A patient on ACE inhibitor developed angioneurotic edema.


Situation: A patient on ACE inhibitor developed angioneurotic edema.
Reaction: Oh my God! Why was ACE inhibitor continued?
Lesson: Make sure that patients on ACE inhibitors are advised to watch for symptoms of urticaria and stop the drug immediately in case swelling of lip, face or tongue develops (Br J Clin Pharmacol 1999;48(6):861–5).

Tuesday, August 9, 2011

Emedinews:Makesure:A patient on ACE inhibitor developed angioneurotic edema


Situation: A patient on ACE inhibitor developed angioneurotic edema.
Reaction: Oh my God! Why was ACE inhibitor continued?
Lesson: Make sure that patients on ACE inhibitors are advised to watch for symptoms of urticaria and stop the drug immediately in case swelling of lip, face or tongue develops 
(Source:Br J Clin Pharmacol 1999;48(6):861–5).

Friday, July 22, 2011

Dr KK Answers: Can ACE inhibitor be combined with ARB in CKD


In a post-hoc analysis of patients with reduced renal function and/or proteinuria from the ONTARGET and TRANSCEND trials combination therapy was associated with a small but significantly increased incidence of end stage renal disease or doubling of the serum Creatinine.
 In patients who had both reduced renal function and proteinuria, combination therapy was associated with a significantly increased risk of ESRD or doubling of the serum Creatinine. Circulation 2011; 123:1098